Clinical Trials Browser

Terminated × Lymphoma, B-Cell, Marginal Zone × Pharmaceutical Preparations × Clear all

NCT00210392 2015-03-30

VELCADE in MALT Lymphoma Pretreated With More Than One Prior Systemic Therapy

Phase 2 Terminated

Lymphoma, B-Cell, Marginal Zone